Jinan, 250000 Shandong, China.
Jinan, 250000 Shandong, China.
Transfus Clin Biol. 2022 Feb;29(1):75-78. doi: 10.1016/j.tracli.2021.06.006. Epub 2021 Jul 2.
To accurately identify ABO blood typing in pre-transfusion testing is very important to ensure blood transfusion safely, which is a major responsibility of blood station.
Eighty-one blood donors samples with ABO blood group typing discrepancy was collected among 61952 donor samples in our blood station from January 2019 to July 2020. Blood group serological method was used to detect ABO blood group. DNA Sequencing was used to determine the genotype. The antibody screening test detects antibodies other than ABO.
In total, 61,952 donor samples were analysed for ABO typing discrepancies. The incidence among blood donors was 0.13% (81/61952). The most common reason of ABO typing discrepancies was due to specific antibody or non-specific agglutination (54.32%, 44/81), mainly anti-M antibody, cold autoantibody, anti-D antibody, anti-N antibody and anti-Lea antibody. The major cause of forward typing discrepancies among blood donors was ABO subgroups (25.93%, 21/81), including 10 cases of A subtype (1 case of A2, 2 cases of A3, 2 cases of Ax, 3 cases of AxB, 1 case of Ael, 1 case of Ahm), 6 cases of B subtype (2 cases of B3, 1 case of Bel, 3 cases of AB3), 2 cases of B subtype (A), 1 case of cisAB, and 2 cases of acquired B. The serum antibody was weakened in 16 cases (19.75%).
The blood types should be correctly identified by combining serology with gene sequencing to ensure the safety of clinical blood transfusion, when the forward and reverse typing discrepancies among the blood donors.
准确鉴定输血前检测中的 ABO 血型对于确保输血安全非常重要,这是血站的主要职责。
收集了本血站 2019 年 1 月至 2020 年 7 月间 61952 名献血者样本中 81 名 ABO 血型定型不符的献血者样本。采用血清学方法检测 ABO 血型,采用 DNA 测序法确定基因型,采用抗体筛查试验检测 ABO 以外的抗体。
共分析了 61952 名献血者的 ABO 定型不符。献血者中的发生率为 0.13%(81/61952)。ABO 定型不符的最常见原因是特异性抗体或非特异性凝集(54.32%,44/81),主要是抗-M 抗体、冷自身抗体、抗-D 抗体、抗-N 抗体和抗-Lea 抗体。献血者正向定型不符的主要原因是 ABO 亚型(25.93%,21/81),包括 A 亚型 10 例(1 例 A2、2 例 A3、2 例 Ax、3 例 AxB、1 例 Ael、1 例 Ahm)、B 亚型 6 例(2 例 B3、1 例 Bel、3 例 AB3)、2 例 B 亚型(A)、1 例 cisAB、2 例获得性 B。16 例(19.75%)血清抗体减弱。
当献血者的正向和反向定型不符时,应结合血清学和基因测序正确鉴定血型,以确保临床输血安全。